Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Shree Ganesh Biotech India LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:539470NSE Symbol: Not ListedP/E(TTM):120
ISIN Demat:INE051N01026Div & Yield %:0EPS(TTM):0.01
Book Value(Rs):1.5699306Market Cap ( Cr.):47.83Face Value(Rs):1
    Change Company 
Date Headline
14-Feb-24 Shree Ganesh Biotech India standalone net profit declines 66.67% in the December 2023 quarter
19-Jan-24 Shree Ganesh Biotech India to hold board meeting
09-Nov-23 Shree Ganesh Biotech India standalone net profit declines 93.33% in the September 2023 quarter
28-Oct-23 Shree Ganesh Biotech India to discuss results
05-Sep-23 Shree Ganesh Biotech India to convene AGM
14-Aug-23 Shree Ganesh Biotech India standalone net profit declines 86.96% in the June 2023 quarter
09-Aug-23 Shree Ganesh Biotech India to announce Quarterly Result
31-May-23 Shree Ganesh Biotech India standalone net profit declines 90.38% in the March 2023 quarter
26-May-23 Shree Ganesh Biotech India to announce Quarterly Result